Transparency Market Research Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Buy Now Request Sample Published Date: April 2014 Single User License: US $ 4795 Multi User License: US $ 7795 206 Pages Report Corporate User License: US $ 10795 REPORT DESCRIPTION 01,April 2014,Albany, New York, USA: In its latest published report titled Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics)and Contract Manufacturing Organizations] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019, Transparency Market Research projects that the global life sciences BPO market will register a 21.5% CAGR over the forecast period The latest addition to the market research report database of Transparency Market Research is a report on the dynamic Life Sciences BPO market. The new report titled Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019 analyzes the core factors influencing this market and potential growth areas as well as restraints besides profiling leading market players in this sector.
According to the report, the global market for Life Sciences business process outsourcing (BPO) was worth USD 152.5 billion in 2012, and expert analysts from the firm predict through in-depth analyses that the market will likely be worth USD 596.0 billion by 2019, demonstrating a healthy compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019. In the recent years, several factors have collectively contributed towards creating a need for Life Sciences BPO. Among these are the increasingly complex rules that govern clinical trials, growing pressure from regulatory bodies, as well as the pressure of rising cost of inputs and R&D. This has compelled market players to look at various alternative means that can help curtail costs without compromising their competitive edge in the market. Many players regard outsourcing as an efficient answer to these concerns, creating a burgeoning market for Life Sciences BPO services worldwide. This market has risen significantly over the past decade and there has been growing acceptance of Life Sciences BPO providers. Furthermore, leading companies in the life sciences sector have also had to deal with patent expirations that have risen in numbers over the last few years. Not to mention the costs associated with the failure of certain drugs and products at the clinical trials stage. These are a few other factors that have spurred a demand for Life Sciences BPO services, or the pharmaceutical outsourcing services as some refer to it. According to the market research report that is based on data obtained from key industry players, a number of pharmaceutical and biotech firms regard outsourcing certain activities as a solution to helping these companies focus on their strategic and core functions. These companies can then engage their highly skilled resources in more productive strategies and cutting-edge projects in-house. The market research report by Transparency Market Research discusses the existing as well as expected market share of the various segments within the Life Sciences BPO market such as the Contract Manufacturing Organizations (CMOs), which is the largest segment by size, and the Contract Research Organizations (CROs). Furthermore, this in-depth research report also discusses the various factors that have directly or indirectly stirred a demand for generic drugs and consequently, a demand for outsourced activities as well. It also throws light on the various advantages experienced by market players via their outsourcing partners on the R&D, compliance, marketing, and productivity front. Within the CMO market, the market for API constitutes the largest segment. Similarly, the services of CROs are regarded as being crucial to the life sciences and pharmaceutical segments in the contemporary scenario because of a myriad of factors. The report by Transparency Market Research discusses the various propellants that have led to these services being sought after (including factors such as rising costs of clinical trials, marketing costs, compliance complexities, and so on). Within the CRO market, the largest segment was that of drug discovery.
Based on various analyses, the report also anticipates that the market for clinical data management services outsourcing is likely to witness the highest rate of growth, pegged at 17.3%, between 2013 and 2019. The market research report then goes on to dissect the global Life Sciences BPO market based on geography, by market share as well as revenue. It predicts that the highest growth within this sector will be observed in the Asia-Pacific region over the forecast period, owing to a number of favorable factors. Table of Content Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation Chapter 2 Executive Summary 2.1 Market Snapshot: Global Life Sciences BPO Market (2012 & 2019) 2.2 Global Pharmaceutical Outsourcing Market, by Service Type, 2012 (USD Billion) 2.3 Global CMO (Contract Manufacturing Organizations) Market, by Service Type, 2012 (USD Billion) 2.4 Global CRO (Contract Research Organizations) Market, by Service Type, 2012 (USD Billion) Chapter 3 Global Life Sciences BPO Market Dynamics 3.1 Introduction 3.1.1 Drivers 3.1.1.1 Rising cost of R&D and decline in productivity 3.1.1.2 Patent expirations to boost CMO industry growth 3.1.1.3 Globalization of drug development with shift of manufacturing activities from high cost to low cost regions 3.1.1.4 Restructuring of pharmaceutical production
Source : http://www.transparencymarketresearch.com/life-sciences-bpomarket.html 3.1.2 Restraints 3.1.2.1 Data safety concerns 3.1.2.2 Stringent and varied regulatory approval processes in different countries 3.1.2.3 Unforeseen Costs has marred the growth of CRO industry 3.1.3 Opportunities 3.1.3.1 Biologics 3.1.3.2 Emerging markets 3.2 Value Chain Analysis 3.2.1 People Skills and Challenges for Life Sciences BPO Services: 3.2.2 Pharmaceutical Outsourcing 3.2.3 Contract Research Outsourcing Market: 3.2.4 Value Chain Analysis: Contract Research Outsourcing Market 3.2.5 Contract Research Outsourcing Services (%), 2012 3.2.5.1 Contract Research Outsourcing Services (%), 2012 3.2.6 Pharmacovigilance 3.2.6.1 Value Chain Analysis: Pharmacovigilance 3.2.7 Biostatistics 3.2.7.1 Value Chain Analysis: Biostatistics 3.2.8 Risk-based Monitoring 3.2.8.1 Value Chain Analysis: Risk based Monitoring 3.2.9 Study Design and Protocol Development 3.2.9.1 Value Chain Analysis: Study Design and Protocol Development 3.2.10 Medical Writing 3.2.10.1 Value Chain Analysis: Medical Writing 3.2.11 Clinical Data Management
3.2.11.1 Value Chain Analysis: Clinical Data Management 3.2.12 Site Management 3.2.12.1 Value Chain Analysis: Site Management 3.2.13 Regulatory Services 3.2.13.1 Value Chain Analysis: Regulatory Services 3.3 Porter s Five Force Analysis: Global Life sciences BPO Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of New Entrants 3.3.4 Threat of Substitutes 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Geography 3.4.1 Market Attractiveness Analysis: Global Life Sciences BPO Market, 2012, by Geography 3.5 Market Attractiveness Analysis of the Global Life Sciences BPO Market, by Europe 3.5.1 Market Attractiveness Analysis: Europe Life Sciences BPO Market, 2012, by Geography Chapter 4 Global Life Sciences BPO Market, by Segments 4.1 Overview 4.2 Pharmaceutical Outsourcing 4.2.1 Contract Manufacturing Outsourcing 4.2.1.1 Active Pharmaceutical Ingredients (API) Manufacturing 4.2.1.1.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 2019 (USD Billion) 4.2.1.2 Final Dosage Form (FDF) Manufacturing 4.2.1.2.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 2019 (USD Billion) 4.2.1.3 Packaging
Billion) 4.2.1.3.1 Global Contract Packaging Market Revenue, 2011 2019 (USD 4.2.2 Contract Research Outsourcing 4.2.2.1 Drug Discovery 4.2.2.1.1 Global Contract Drug Discovery Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.2 Pre-Clinical Studies 4.2.2.2.1 Global Contract Pre-clinical Studies Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.3 Early Phase Clinical Research Services (Phase I / IIa) 4.2.2.3.1 Global Contract Early Phase Clinical Research Services (Phase I / IIa) Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.4 Phase IIb / IIIa 4.2.2.4.1 Global Contract Clinical Research Services (Phase IIb / IIIa) Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.5 Phase IIIb / IV (Peri/Post Approval Phase / Post Marketing Surveillance) 4.2.2.5.1 Global Contract Clinical Research Services (Phase IIIb / IV) Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.6 Medical Writing 4.2.2.6.1 Global Contract Medical Writing Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.7 Pharmacovigilance 4.2.2.7.1 Global Contract Pharmacovigilance Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.8 Clinical Data Management 4.2.2.8.1 Global Contract Clinical Data Management Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.9 Regulatory Services 4.2.2.9.1 Global Contract Regulatory Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.10 Clinical Monitoring
4.2.2.10.1 Global Contract Clinical Monitoring Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.11 Biostatistics 4.2.2.11.1 Global Contract Bio-statistics Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.12 Protocol Development 4.2.2.12.1 Global Contract Protocol Development Services Outsourcing Market Revenue, 2011 2019 (USD Billion) 4.2.2.13 Site Management 4.2.2.13.1 Global Contract Site Management Services Outsourcing Market Revenue, 2011 2019 (USD Billion) Chapter 5 Global Life Sciences BPO Market, by Geography 5.1 Overview 5.1.1 Global Life Sciences BPO Market, by Geography, 2011 2019 (USD Billion) 5.1.2 Comparative Analysis: Global Life Sciences BPO Services Market, by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3 Europe 5.3.1 Europe Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.2 Germany 5.3.2.1 Germany Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.2.2 Germany Contract Manufacturing Outsourcing Services Market, 2011 2019 (USD Million) 5.3.2.3 Germany Contract Research Outsourcing Services Market, 2011 2019 (USD Million) 5.3.3 U.K. 5.3.3.1 U.K. Life Sciences BPO Market, 2011 2019 (USD Billion)
5.3.3.2 U.K. Contract Manufacturing Outsourcing Services Market, 2011 2-019 (USD Billion) Million) 5.3.3.3 U.K. Contract Research Outsourcing Services Market, 2011 2019 (USD 5.3.4 France 5.3.4.1 France Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.4.2 France Contract Manufacturing Outsourcing Service Market, 2011 2019 (USD Million) 5.3.4.3 France Contract Research Outsourcing Services Market, 2011 2019 (USD Million) 5.3.5 Italy 5.3.5.1 Italy Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.5.2 Italy Contract Manufacturing Outsourcing Services Market, 2011 2019 (USD Million) Million) 5.3.5.3 Italy Contract Research Outsourcing Services Market, 2011 2019 (USD 5.3.6 Spain 5.3.6.1 Spain Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.6.2 Spain Contract Manufacturing Outsourcing Services Market, 2011 2019 (USD Million) Million) 5.3.6.3 Spain Contract Research Outsourcing Services Market, 2011 2019 (USD 5.3.7 Switzerland 5.3.7.1 Switzerland Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.7.2 Switzerland Contract Manufacturing Outsourcing Services Market, 2011 2019 (USD Million) 5.3.7.3 Switzerland Contract Research Outsourcing Services Market, 2011 2019 (USD Million) 5.3.8 Rest of Europe (ROE) 5.3.8.1 ROE Life Sciences BPO Market, 2011 2019 (USD Billion) 5.3.8.2 ROE Contract Manufacturing Outsourcing Services Market, 2011 2019 (USD Million)
Million) 5.3.8.3 ROE Contract Research Outsourcing Services Market, 2011 2019 (USD 5.4 Asia-Pacific 5.4.1 Asia-Pacific Life Sciences BPO Market, 2011 2019 (USD Billion) 5.5 RoW 5.5.1 RoW Life Sciences BPO Market, 2011 2019 (USD Billion) Chapter 6 Global Life Sciences BPO Market Share Analysis 6.1 Market Share Analysis by Key Players of Global CRO Market 6.1.1 Global CRO Market Share Analysis, by Key Players, 2012 (%) 6.2 Market Share Analysis by Key Players of Global CMO Market 6.2.1 Global CMO Market Share Analysis, by Key Players, 2012 (%) Chapter 7 Recommendations 7.1 Success Strategies 7.1.1 Expand Market into Emerging Countries 7.1.2 Ensure Data Confidentiality and Regulatory Compliance 7.1.3 Timely Entry in the Market 7.1.4 Offer a Wide Range of Research and Manufacturing Services 7.1.5 Developing Strategic Alliances and Partnerships With Pharmaceutical and Biotechnology Companies 7.1.6 Risk Management Chapter 8 Company Profiles 8.1 Accenture, Plc 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio
8.1.4 Business Strategies 8.1.4.1 Mergers and acquisitions 8.1.5 Recent Developments 8.2 Boehringer Ingelheim GmbH 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.4.1 Research And Development For Medical Innovation 8.2.5 Recent Developments 8.3 Catalent Pharma Solutions, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.4.1 Geographical expansion of business 8.3.4.2 Diversification of product portfolio 8.3.5 Recent Developments 8.4 Charles River Laboratories International, Inc. (CRL) 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.4.1 Expansion of services offered 8.4.4.2 New product launches and Innovation 8.4.4.3 Strategic acquisitions 8.4.5 Recent Developments
8.5 Cognizant Technology Solutions 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.4.1 Expansion of geographical footprint 8.5.4.2 Expansion product portfolio 8.5.4.3 Highly-skilled manpower 8.5.4.4 Strategic acquisitions 8.5.5 Recent Developments 8.6 Covance, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.4.1 New product development and innovation 8.6.4.2 Agreements and collaborations 8.6.4.3 Strategic acquisitions 8.6.4.4 Geographical expansion of business 8.6.5 Recent Developments 8.7 DSM 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.4.1 Strategic acquisitions 8.7.5 Recent Developments
8.8 Fareva 8.8.1 Company Overview 8.8.2 Product Portfolio 8.8.3 Business Strategies 8.8.3.1 Extensive product portfolio 8.8.3.2 Safety environment for staff 8.8.3.3 Commitment to quality 8.8.4 Recent Developments 8.9 ICON, Plc 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.4.1 Business expansion in APAC region 8.9.4.2 Expansion of services offered 8.9.5 Recent Developments 8.10 Infosys 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.4.1 Extensive product portfolio 8.10.4.2 Geographical expansion of business 8.10.5 Recent Developments 8.11 International Business Machines Corporation 8.11.1 Company overview 8.11.2 Financial overview
8.11.3 Product Portfolio 8.11.4 Business strategies 8.11.4.1 Focus on increasing facilities for predictive analytics 8.11.4.2 Geographic Expansion 8.11.5 Recent developments 8.12 Lonza Group 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.4.1 Investment in emerging economies 8.12.4.2 Mergers and acquisitions 8.12.5 Recent Developments 8.13 Pharmaceutical Product Development, Inc. (PPD, Inc.) 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategies 8.13.4.1 Expanding geographic presence 8.13.4.2 Incorporation of innovative technologies 8.13.4.3 Strategic acquisitions 8.13.4.4 New product launch and innovation 8.13.5 Recent Developments 8.14 Parexel International Corporation 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio
8.14.4 Business Strategies 8.14.4.1 Strong presence in Asia and emerging markets 8.14.4.2 Strategic alliances 8.14.4.3 Mergers & Acquisitions 8.14.5 Recent Developments 8.15 Patheon, Inc. 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio 8.15.4 Business Strategies 8.15.4.1 Strategic acquisitions 8.15.4.2 Geographical expansion of business 8.15.5 Recent Developments 8.16 Piramal Healthcare 8.16.1 Company Overview 8.16.2 Financial Overview 8.16.3 Product Portfolio 8.16.4 Business Strategies 8.16.4.1 Expansion of services offered 8.16.5 Recent Developments 8.17 PRA International, Inc. 8.17.1 Company Overview 8.17.2 Financial Overview 8.17.3 Product Portfolio 8.17.4 Business Strategies 8.17.4.1 Mergers and acquisitions 8.17.5 Recent Developments
8.18 Quintiles Transnational Corporation 8.18.1 Company Overview 8.18.2 Financial Overview 8.18.3 Product Portfolio 8.18.4 Business Strategies 8.18.4.1 Expansion of services 8.18.4.2 Acquisitions and partnerships 8.18.4.3 Innovation in services offered 8.18.5 Recent Developments 8.19 Wipro Limited 8.19.1 Company Overview 8.19.2 Financial Overview 8.19.3 Product Portfolio 8.19.4 Business Strategies 8.19.4.1 Geographical Expansion Chapter 9 List of the Companies 9.1 List of Companies Offering Contract Research Outsourcing Services in North America. 9.3 List of Companies Offering Contract Research Outsourcing Services in Europe. 9.3.1 List of Contract Research Organizations in France 9.3.2 List of Contract Research Organizations in Italy 9.3.4 List of Contract Research Organizations in Germany 9.3.5 List of Contract Research Organizations in Spain 9.3.6 List of Contract Research Organizations in United Kingdom 9.3.7 List of Contract Research Organizations in Switzerland
About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/